Bank of America’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-259,800
Closed -$966K 8301
2021
Q4
$966K Sell
259,800
-198,800
-43% -$1.22M ﹤0.01% 5330
2021
Q3
$3.39M Sell
458,600
-91,400
-17% -$782K ﹤0.01% 3951
2021
Q2
$7.33M Sell
550,000
-150,000
-21% -$1.47M ﹤0.01% 3138
2021
Q1
$5.29M Buy
+700,000
New +$7.9M ﹤0.01% 3336

Other funds holding CLOV

Bank of America's CLOV Position: Q1 2026 in Review

Bank of America reduced its Clover Health Investments (CLOV) stake by 16% in Q1 2026, selling an estimated $155K and leaving 371,114 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #4755.

Bank of America first reported a position in CLOV in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.2M in Q2 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Bank of America held 371,114 shares of Clover Health Investments worth $653K as of Q1 2026.
  • Bank of America sold 71,346 Clover Health Investments shares in Q1 2026, an estimated $155K.
  • Clover Health Investments made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4755 holding.
  • Bank of America first reported a position in Clover Health Investments in Q4 2020 and has held it in 22 quarters since.
  • Bank of America's Clover Health Investments position peaked at $11.2M in Q2 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.